2 completed, 1 suspended. 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Suspended 1 |
Follow abarelix: new trials by email Literature Review of abarelix trials Research Report on abarelix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Plenaxis® Experience Study Plenaxis - Prostate Cancer | Phase 4 | Suspended | PRAECIS Pharmaceuticals Inc. | 2000 | 2004-06-01 | 2006-09-19 |
| Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy Plenaxis - Prostate Cancer | Phase 2 | Completed | PRAECIS Pharmaceuticals Inc. | 22 | 2004-05-01 | 2006-09-19 |
| Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer Abarelix, Goserelin plus Bicalutamide - Prostate Cancer | Phase 3 | Completed | Speciality European Pharma Limited | 177 | 1999-01-01 | 2009-02-11 |
Prostatic Neoplasms (3) · Neoplasm Metastasis (1) · Neoplasms (1)
PRAECIS Pharmaceuticals Inc. (2) · Speciality European Pharma Limited (1)
United States (2)
Frans M J Debruyne, MD (1) · Gerald Riedel, PhD (1) · Marc Garnick, MD (1)